"NEDD8 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A ubiquitin-like protein that functions in CELL CYCLE regulation and embryogenesis. It is attached covalently to its substrates following activation by the UBIQUITIN-ACTIVATING ENZYME E1-UBA3 enzyme complex. NEDD8 attaches to CULLINS, activating their E3 UBIQUITIN LIGASE activity, to promote polyubiquitination and degradation of CYCLINS and regulatory proteins
| Descriptor ID |
D000075687
|
| MeSH Number(s) |
D12.776.947.218
|
| Concept/Terms |
NEDD8 Protein- NEDD8 Protein
- Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 8
- Neural Precursor Cell Expressed Developmentally Down Regulated Protein 8
- NEDD-8 Protein
- NEDD 8 Protein
- Ubiquitin-like Protein NEDD8
- NEDD8, Ubiquitin-like Protein
- Ubiquitin like Protein NEDD8
|
Below are MeSH descriptors whose meaning is more general than "NEDD8 Protein".
Below are MeSH descriptors whose meaning is more specific than "NEDD8 Protein".
This graph shows the total number of publications written about "NEDD8 Protein" by people in this website by year, and whether "NEDD8 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "NEDD8 Protein" by people in Profiles.
-
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors. Clin Pharmacol Drug Dev. 2023 03; 12(3):257-266.
-
Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. Proc Natl Acad Sci U S A. 2022 02 08; 119(6).
-
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood. 2010 May 06; 115(18):3796-800.